Genomics England is was established to implement the 100,000 Genomes Project, sequencing whole genomes from NHS patients with rare diseases, and their families, as well as patients with cancer. The initiative marked a significant step in advancing the field of genomic medicine in the UK. They equip researchers to find the causes of disease and develop new treatments – with patients and participants at the heart of it all.

In this compelling session at NextMed Health (http://NextMed.Health), Baroness Nicola Blackwood, Chair of Genomics England, and Chris Wigley, CEO of Genomics England, cover the findings, implications, and ways their work is helping the NHS embed and integrate genomics into routine healthcare.

Their conversation at NextMed Health painted a picture of a future where genomics is deeply integrated into healthcare, offering more personalized, effective, and equitable health solutions.

Learn more about Genomics England: https://GenomicsEngland.co.uk

NextMed Health is a global community and platform exploring and catalyzing the future of health and biomedicine: Join us at http://NextMed.Health/join